Flagship Pioneering, LLC Long-Term Concentrated

CIK: 0001400240 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 17, 2021

Total Value ($000): $6,244,355 (100.0% shares, 0.0% debt)

Holdings (12)

MRNA Moderna Inc 43.2%

Value ($000) $2,695,084 Shares 20,581,016 Est. Cost $16.43 Unrealized +781.8%

SANA Sana Biotechnology Inc 18.4%

Value ($000) $1,145,980 Shares 34,239,018 Est. Cost $32.56 Unrealized 0.0%

— Rubius Therapeutics Inc 16.3%

Value ($000) $1,020,423 Shares 38,506,526 Est. Cost $24.00 Unrealized —

— Seres Therapeutics Inc 4.8%

Value ($000) $302,137 Shares 14,673,973 Est. Cost $8.55 Unrealized —

— Evelo Biosciences Inc 3.9%

Value ($000) $246,421 Shares 23,030,069 Est. Cost $10.39 Unrealized —

— Sigilon Therapeutics Inc 3.7%

Value ($000) $231,778 Shares 10,370,369 Est. Cost $48.03 Unrealized —

FHTX Foghorn Therapeutics Inc 2.7%

Value ($000) $167,045 Shares 12,674,120 Est. Cost $19.16 Unrealized -14.5%

KLDO Kaleido Biosciences Inc 2.5%

Value ($000) $158,562 Shares 19,575,710 Est. Cost $13.01 Unrealized -16.3%

DNLI Denali Therapeutics Inc 2.5%

Value ($000) $155,898 Shares 2,730,263 Est. Cost $17.97 Unrealized +272.5%

— Axcella Health Inc 1.0%

Value ($000) $59,729 Shares 12,548,414 Est. Cost $8.17 Unrealized —

— Codiak Biosciences Inc 0.6%

Value ($000) $39,318 Shares 2,607,303 Est. Cost $32.30 Unrealized —

— Syros Pharmaceuticals Inc 0.4%

Value ($000) $21,980 Shares 2,938,494 Est. Cost $13.87 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MRNA	Moderna Inc	20,581,016	$2,695,084	43.2%	$16.43	+781.8%	COM	60770K107
SANA	Sana Biotechnology Inc	34,239,018	$1,145,980	18.4%	$32.56	0.0%	COM	799566104
—	Rubius Therapeutics Inc	38,506,526	$1,020,423	16.3%	$24.00	—	COM	78116T103
—	Seres Therapeutics Inc	14,673,973	$302,137	4.8%	$8.55	—	COM	81750R102
—	Evelo Biosciences Inc	23,030,069	$246,421	3.9%	$10.39	—	COM	299734103
—	Sigilon Therapeutics Inc	10,370,369	$231,778	3.7%	$48.03	—	COM	82657L107
FHTX	Foghorn Therapeutics Inc	12,674,120	$167,045	2.7%	$19.16	-14.5%	COM	344174107
KLDO	Kaleido Biosciences Inc	19,575,710	$158,562	2.5%	$13.01	-16.3%	COM	483347100
DNLI	Denali Therapeutics Inc	2,730,263	$155,898	2.5%	$17.97	+272.5%	COM	24823R105
—	Axcella Health Inc	12,548,414	$59,729	1.0%	$8.17	—	COM	05454B105
—	Codiak Biosciences Inc	2,607,303	$39,318	0.6%	$32.30	—	COM	192010106
—	Syros Pharmaceuticals Inc	2,938,494	$21,980	0.4%	$13.87	—	COM	87184Q107